The public science base of US biotechnology: A citation-weighted approach

G. Steven McMillan; Robert D. Hamilton

doi:10.1007/s11192-007-1701-4

The public science base of US biotechnology: A citation-weighted approach

G. Steven McMillan, Robert D. Hamilton

Division of Social Sciences (Abington)

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

In previous research we examined the science base of US biotechnology utilizing several unique patent and scientific paper databases (McMillan et al., 2000). Our findings highlighted the importance of public science in this industry. In this current research effort, we extend that analysis to include the subsequent citations those biotechnology patents received. Our conclusions are that the reliance on public science is stable when adjusted for forward citations, but the impact of different funding sources does change when citation weights are added. The science policy implications of these findings and future research opportunities are discussed.

Original language	English (US)
Pages (from-to)	3-10
Number of pages	8
Journal	Scientometrics
Volume	72
Issue number	1
DOIs	https://doi.org/10.1007/s11192-007-1701-4
State	Published - Jul 2007

All Science Journal Classification (ASJC) codes

General Social Sciences
Computer Science Applications
Library and Information Sciences

Access to Document

10.1007/s11192-007-1701-4

Cite this

@article{b8410bbb3a944e0cb8ab36dff1594ad0,

title = "The public science base of US biotechnology: A citation-weighted approach",

abstract = "In previous research we examined the science base of US biotechnology utilizing several unique patent and scientific paper databases (McMillan et al., 2000). Our findings highlighted the importance of public science in this industry. In this current research effort, we extend that analysis to include the subsequent citations those biotechnology patents received. Our conclusions are that the reliance on public science is stable when adjusted for forward citations, but the impact of different funding sources does change when citation weights are added. The science policy implications of these findings and future research opportunities are discussed.",

author = "McMillan, {G. Steven} and Hamilton, {Robert D.}",

note = "Funding Information: National Cancer Institute National Institute of General Medicine Sciences National Institute of Allergy and Infectious Diseases National Heart, Lung and Blood Institute American Cancer Society National Institute of Arthritis and Musculoskeletal Diseases National Science Foundation American Heart Association National Centre for Research Resources US Universities and Medical Schools (internally supported)",

year = "2007",

month = jul,

doi = "10.1007/s11192-007-1701-4",

language = "English (US)",

volume = "72",

pages = "3--10",

journal = "Scientometrics",

issn = "0138-9130",

publisher = "Springer Netherlands",

number = "1",

}

TY - JOUR

T1 - The public science base of US biotechnology

T2 - A citation-weighted approach

AU - McMillan, G. Steven

AU - Hamilton, Robert D.

N1 - Funding Information: National Cancer Institute National Institute of General Medicine Sciences National Institute of Allergy and Infectious Diseases National Heart, Lung and Blood Institute American Cancer Society National Institute of Arthritis and Musculoskeletal Diseases National Science Foundation American Heart Association National Centre for Research Resources US Universities and Medical Schools (internally supported)

PY - 2007/7

Y1 - 2007/7

N2 - In previous research we examined the science base of US biotechnology utilizing several unique patent and scientific paper databases (McMillan et al., 2000). Our findings highlighted the importance of public science in this industry. In this current research effort, we extend that analysis to include the subsequent citations those biotechnology patents received. Our conclusions are that the reliance on public science is stable when adjusted for forward citations, but the impact of different funding sources does change when citation weights are added. The science policy implications of these findings and future research opportunities are discussed.

AB - In previous research we examined the science base of US biotechnology utilizing several unique patent and scientific paper databases (McMillan et al., 2000). Our findings highlighted the importance of public science in this industry. In this current research effort, we extend that analysis to include the subsequent citations those biotechnology patents received. Our conclusions are that the reliance on public science is stable when adjusted for forward citations, but the impact of different funding sources does change when citation weights are added. The science policy implications of these findings and future research opportunities are discussed.

UR - http://www.scopus.com/inward/record.url?scp=34547312937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547312937&partnerID=8YFLogxK

U2 - 10.1007/s11192-007-1701-4

DO - 10.1007/s11192-007-1701-4

M3 - Article

AN - SCOPUS:34547312937

SN - 0138-9130

VL - 72

SP - 3

EP - 10

JO - Scientometrics

JF - Scientometrics

IS - 1

ER -

The public science base of US biotechnology: A citation-weighted approach

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this